| GC33090-10mg |
|
915720-21-7 |
|
0 |
C17H19ClFN7O |
|
|
|
| GC33090-5mg |
|
915720-21-7 |
|
0 |
C17H19ClFN7O |
|
|
|
| GC33090-2mg |
|
915720-21-7 |
|
0 |
C17H19ClFN7O |
|
|
|
| GC33090-10mM(1mLinDMSO) |
|
915720-21-7 |
|
0 |
C17H19ClFN7O |
|
|
|
| GC33089-25mg |
|
16960-16-0 |
Tetracosactide (Tetracosactrin)
|
0 |
C136H210N40O31S |
|
|
|
| GC33089-10mg |
|
16960-16-0 |
Tetracosactide (Tetracosactrin)
|
0 |
C136H210N40O31S |
|
|
|
| GC33089-5mg |
|
16960-16-0 |
Tetracosactide (Tetracosactrin)
|
0 |
C136H210N40O31S |
|
|
|
| GC33089-1mg |
|
16960-16-0 |
Tetracosactide (Tetracosactrin)
|
0 |
C136H210N40O31S |
|
|
|
| GC33088-100mg |
|
121494-09-5 |
|
0 |
C30H34BrClN4O4 |
|
|
|
| GC33088-50mg |
|
121494-09-5 |
|
0 |
C30H34BrClN4O4 |
|
|
|
| GC33088-10mg |
|
121494-09-5 |
|
0 |
C30H34BrClN4O4 |
|
|
|
| GC33088-5mg |
|
121494-09-5 |
|
0 |
C30H34BrClN4O4 |
|
|
|
| GC33088-1mg |
|
121494-09-5 |
|
0 |
C30H34BrClN4O4 |
|
|
|
| GC33088-10mM(1mLinDMSO) |
|
121494-09-5 |
|
0 |
C30H34BrClN4O4 |
|
|
|
| GC33087-5mg |
|
1430089-64-7 |
2,4-Pyrimidinediamine with linker
|
0 |
C19H24N8 |
|
|
|
| GC33087-50mg |
|
1430089-64-7 |
2,4-Pyrimidinediamine with linker
|
0 |
C19H24N8 |
|
|
|
| GC33087-10mg |
|
1430089-64-7 |
2,4-Pyrimidinediamine with linker
|
0 |
C19H24N8 |
|
|
|
| GC33087-100mg |
|
1430089-64-7 |
2,4-Pyrimidinediamine with linker
|
0 |
C19H24N8 |
|
|
|
| GC33086-5mg |
|
184582-62-5 |
|
0 |
C18H20N2O2S |
|
|
|
| GC33085-10mg |
|
80508-81-2 |
|
0 |
C22H30O5 |
|
|
|
